{"title": "Las part\u00edculas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunolog\u00eda", "author": "De Ganz\u00f3; Agust\u00edn Francisco; Borio; Cristina Silvia; Lozano; Mario Enrique; Pastorini; Mercedes; Go\u00f1i; Sandra Elizabeth", "url": null, "hostname": null, "description": "CONICET Digital, el repositorio institucional del CONICET, un servicio gratuito para acceder a la producci\u00f3n cient\u00edfico-tecnol\u00f3gica de investigadores, becarios y dem\u00e1s personal del CONICET.", "sitename": "Universidad Nacional de Quilmes. Secretar\u00eda de Posgrado", "date": "2018-06-20", "id": null, "license": "CC BY-NC-SA 2.5", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Art\u00edculoLas vacunas m\u00e1s exitosas utilizadas en la actualidad han sido desarrolladas utilizando m\u00e9todos convencionales que siguen el paradigma establecido por Pasteur hace m\u00e1s de un siglo, de \"aislar, inactivar e inyectar\u201d el microorganismo causante de la enfermedad y, de esta forma, imitar una infecci\u00f3n natural. Con la llegada de la metagen\u00f3mica, la selecci\u00f3n de ant\u00edgenos basada en la informaci\u00f3n gen\u00f3mica ha desempe\u00f1ado un papel importante en el descubrimiento de nuevos inmun\u00f3genos para el dise\u00f1o de vacunas. Un enfoque que ha utilizado esta estrategia ha sido denominado \"vacunolog\u00eda inversa\" y ha permitido el escrutinio del repertorio antig\u00e9nico potencial de un organismo a trav\u00e9s de su genoma, gracias a herramientas bioinform\u00e1ticas predictivas. Mediante m\u00e9todos in vitro de clonado molecular, las prote\u00ednas seleccionadas como ant\u00edgenos son producidas a mediana escala y evaluadas en modelos animales para ensayar su capacidad de generar una respuesta inmune protectora. El objetivo principal es evaluar la capacidad de la respuesta inmune de eliminar o neutralizar al pat\u00f3geno al momento de la infecci\u00f3n. Cuanto m\u00e1s neutralizante es la respuesta inmune ante un ant\u00edgeno espec\u00edfico, mayor potencial tendr\u00e1 el mismo como vacuna. En este review se resume la evoluci\u00f3n de la vacunolog\u00eda desde sus comienzos en el siglo XVIII con la aparici\u00f3n de la vacuna de la viruela hasta el desarrollo de la vacunolog\u00eda inversa, haciendo especial hincapi\u00e9 en el desarrollo de VLPs como plataformas vacunales y su futuro en medicina preventiva.The most successful vaccines have been developed using conventional methods that follow the paradigm established by Pasteur in the XIX century: \"to isolate, inactivate and inject\" the pathogen microorganism and mimic a natural infection. With the arrival of metagenomics, the selection of antigens based on genomic information has played an important role in the discovery of new immunogens for vaccine design. The main approach that has used this strategy has been called \"reverse vaccinology\" and allows to screen the entire potential antigenic repertoire of an organism through its genome, using predictive bioinformatic tools. Using in vitro molecular cloning methods, the protein or proteins selected as antigens may be artificially produced to evaluate their capacity of generating a protective immune response in animal models. The main aim of this approach is to evaluate the ability of the immune response to eliminate or neutralize the pathogen at the time of infection. Those antigens capable of generate a specific immune response with neutralizing activity for future natural infections are the best candidate vaccines. This review summarizes the evolution of vaccinology since its inception in the eighteenth century with the emergence of the smallpox vaccine to the development of reverse vaccinology, with special emphasis on the development of VLPs as vaccine platforms and their future in preventive medicine.\nLas part\u00edculas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunolog\u00eda\nT\u00edtulo: Virus-like particles and its applications in vaccinology\n[de Ganz\u00f3, Agust\u00edn Francisco](/author/61812); [Borio, Cristina Silvia](/author/27159); [Lozano, Mario Enrique](/author/5138); [Pastorini, Mercedes](/author/144676); [Go\u00f1i, Sandra Elizabeth](/author/24727)\nFecha de publicaci\u00f3n: 06/2018\nEditorial: Universidad Nacional de Quilmes. Secretar\u00eda de Posgrado\nRevista: Divulgatio\ne-ISSN: 2591-3530\nIdioma: Espa\u00f1ol\nTipo de recurso: Art\u00edculo publicado\nClasificaci\u00f3n tem\u00e1tica:\nResumen\nPalabras clave:\n[VLPs ,](\n/discover?filtertype=subject&filter_relational_operator=equals&filter=VLPs) [Vacunolog\u00eda ,](\n/discover?filtertype=subject&filter_relational_operator=equals&filter=Vacunolog\u00eda) [Plataforma vacunal ,](\n/discover?filtertype=subject&filter_relational_operator=equals&filter=Plataforma vacunal) [Prote\u00ednas recombinantes](\n/discover?filtertype=subject&filter_relational_operator=equals&filter=Prote\u00ednas recombinantes)\nArchivos asociados\nLicencia\nIdentificadores\nColecciones\n[Articulos(SEDE CENTRAL)](\n/handle/11336/36/discover\n)\nArticulos de SEDE CENTRAL\nCitaci\u00f3n\nde Ganz\u00f3, Agust\u00edn Francisco; Borio, Cristina Silvia; Lozano, Mario Enrique; Pastorini, Mercedes; Go\u00f1i, Sandra Elizabeth; Las part\u00edculas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunolog\u00eda; Universidad Nacional de Quilmes. Secretar\u00eda de Posgrado; Divulgatio; 2; 5; 6-2018; 48-76\nCompartir\nEstad\u00edsticas\nVisualizaciones: 74\nDescargas: 70\nDescargas: 70", "language": null, "image": null, "pagetype": "website", "links": ["/", "/", "#", "/explorar-autores", "/subject/", "/community-list", "/wp/estadisticas/", "#", "/wp/novedades-2/noticias/", "/wp/novedades-2/boletines/", "#", "/wp/ayuda/", "/wp/ayuda/datos-de-investigacion/", "#", "/wp/acerca-de/conicet-digital/", "/wp/acerca-de/equipo/", "/wp/acerca-de/red/", "/wp/contacto/?ref=http://ri.conicet.gov.ar/handle/11336/176850", "#ds-main", "#anchorAbstract", "/handle/11336/176850/statistics", "/author/61812", "/author/27159", "/author/5138", "/author/144676", "/author/24727", "/discover?filtertype=subjectClassification&filter_relational_operator=authority&filter=36", "\n\t                \t/discover?filtertype=subject&filter_relational_operator=equals&filter=VLPs", "\n\t                \t/discover?filtertype=subject&filter_relational_operator=equals&filter=Vacunolog\u00eda", "\n\t                \t/discover?filtertype=subject&filter_relational_operator=equals&filter=Plataforma vacunal", "\n\t                \t/discover?filtertype=subject&filter_relational_operator=equals&filter=Prote\u00ednas recombinantes", "/handle/11336/176850?show=full", "/bitstream/handle/11336/176850/CONICET_Digital_Nro.a68be3ab-0892-4975-a169-726e073ac89b_B.pdf?sequence=2&isAllowed=y", "/bitstream/handle/11336/176850/CONICET_Digital_Nro.a68be3ab-0892-4975-a169-726e073ac89b_B.pdf?sequence=2&isAllowed=y", "https://creativecommons.org/licenses/by-nc-sa/2.5/ar/", "http://hdl.handle.net/11336/176850", "http://revistadivulgatio.web.unq.edu.ar/?entradas-ejemplares=las-particulas-similares-a-virus-vlps-virus-likeparticles-y-su-empleo-en-vacunologia", "https://ridaa.unq.edu.ar/handle/20.500.11807/2776", "\n\t\t                            /handle/11336/36/discover\n\t\t               ", "#", null, null, "\n\t\t\t\thttp://scholar.google.com/scholar?as_occt=title&as_q=Las part\u00edculas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunolog\u00eda", "\n\t\t\t\thttp://www.mendeley.com/import/?url=https://ri.conicet.gov.ar/handle/11336/176850", null, "#", "https://www.facebook.com/CONICETDigital", "https://twitter.com/CONICETDigital", "https://www.instagram.com/conicetdigital_repo/", "https://www.youtube.com/user/ConicetDialoga", "https://soundcloud.com/conicet", "https://creativecommons.org/licenses/by/2.5/ar/", "https://www.argentina.gob.ar/educacion", "https://www.conicet.gov.ar/", "/", "/explorar-autores", "/subject/", "/community-list", "/wp/estadisticas/", "/wp/novedades-2/noticias/", "/wp/novedades-2/boletines/", "/wp/ayuda/", "/wp/acerca-de/conicet-digital/", "/wp/acerca-de/equipo/", "/wp/acerca-de/red/", "/wp/contacto/?ref=http://ri.conicet.gov.ar/handle/11336/176850", "https://www.conicet.gov.ar/terminos-de-uso-y-politicas-de-privacidad/", "https://www.conicet.gov.ar/terminos-de-uso-y-politicas-de-privacidad/", "https://www.conicet.gov.ar/terminos-de-uso-y-politicas-de-privacidad/"]}